Prenatal cannabis use was associated with a slew of serious adverse maternal health outcomes later in pregnancy, according to a large cohort study.
Compared with non-use, prenatal cannabis use was associated with increased risks of:
Placental abruption (adjusted risk ratio [aRR] 1.19, 95% CI 1.05-1.36)Gestational hypertension (aRR 1.17, 95% CI 1.13-1.21)Weight gain greater than guidelines (aRR 1.09, 95% CI 1.08-1.10)Preeclampsia (aRR 1.08, 95% CI 1.01-1.15)Weight gain less than guidelines (aRR 1.05, 95% CI 1.01-1.08)A dose-response association was also found with regard to risk of gestational hypertension, with those who used cannabis daily facing the highest risk (aRR 1.24, 95% CI 1.14-1.36), followed by weekly (aRR 1.21, 95% CI 1.11-1.31) versus never-use (P
Source : MedPageToday